Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative | Molecular Psychiatry
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
New Assay, New Cohorts—Plasma p-Tau181 Looks Even Better | ALZFORUM
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition | Journal of Neurology, Neurosurgery & Psychiatry
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays | Neurology
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression | Alzheimer's Research & Therapy | Full Text
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals | medRxiv
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease | Alzheimer's Research & Therapy | Full Text
CSF levels of t-tau ( a ) and p-tau 181 ( b ) in patients with... | Download Scientific Diagram
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Phospho-Tau (Thr181) Antibody | Cell Signaling Technology
![Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine](https://www.thelancet.com/cms/asset/40dffde0-5333-4ccf-9aee-5eca64f597b8/gr1.jpg "Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine")
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease | PLOS ONE
Association of plasma P-tau181 with CSF P-tau181 and Aβ PET (a)... | Download Scientific Diagram
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
![Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation](https://labchem-wako.fujifilm.com/us/product_data/images/03666535_img02.png "Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation")
Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation
Phospho-Tau (Thr181) antibody (28866-1-AP) | Proteintech
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
IJMS | Free Full-Text | Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration
